ACADIA Pharmaceuticals
ACAD
#3824
Rank
NZ$4.13 B
Marketcap
$24.77
Share price
1.44%
Change (1 day)
-11.35%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): -$1.49

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.54. In 2022 the company made an earnings per share (EPS) of -$2.24 a decrease over its 2021 EPS that were of -$1.75.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.49-33.4%
2022-$2.2427.62%
2021-$1.75-41.67%
2020-$3.0112.5%
2019-$2.67-17.95%
2018-$3.26-17.02%
2017-$3.930.43%
2016-$3.9143.56%
2015-$2.7273.4%
2014-$1.57113.64%
2013-$0.7418.92%
2012-$0.62-15.91%
2011-$0.74-210%
2010$0.67-133.61%
2009-$1.99-30.81%
2008-$2.877.5%
2007-$2.67-0.62%
2006-$2.694.55%
2005-$2.57-14.61%
2004-$3.01-84.26%
2003-$19.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$0.45-129.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.11-302.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.07-690.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.53-1,631.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63-531.52%๐Ÿ‡บ๐Ÿ‡ธ USA